Company Oncolytics Biotech Inc. Toronto S.E.
Equities
CA6823101077
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Matthew Coffey
CEO | Chief Executive Officer | - | 11-05-10 |
Kirk Look
DFI | Director of Finance/CFO | - | 03-03-31 |
Thomas Heineman
CTO | Chief Tech/Sci/R&D Officer | - | 20-07-31 |
Jon Patton
IRC | Investor Relations Contact | - | 20-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Rigby
BRD | Director/Board Member | 56 | 22-09-06 |
Patricia Andrews
BRD | Director/Board Member | 66 | Jan. 08 |
Bernd Seizinger
BRD | Director/Board Member | 67 | 15-06-07 |
James Parsons
BRD | Director/Board Member | 58 | 22-06-15 |
Angela Holtham
BRD | Director/Board Member | 73 | 14-06-17 |
Matthew Coffey
CEO | Chief Executive Officer | - | 11-05-10 |
Wayne Pisano
CHM | Chairman | 69 | 13-05-08 |
Deborah Brown
BRD | Director/Board Member | - | 17-11-01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 75,419,768 | 72,478,872 ( 96.10 %) | 0 | 96.10 % |
Company contact information
Oncolytics Biotech, Inc.
322–11th Avenue SW Suite 804
T2R 0C5, Calgary
+
http://www.oncolyticsbiotech.comSector
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |